Has the use of novel therapies improved survival in the general population of patients with myeloma and chronic lymphocytic leukaemia (CLL) in the UK?

Alexandra Gwen Smith; Timothy Charles Bagguley; Debra Howell; Cathy Burton; Eve Roman; Russell Patmore

Has the use of novel therapies improved survival in the general population of patients with myeloma and chronic lymphocytic leukaemia (CLL) in the UK?

Alexandra Gwen Smith, Timothy Charles Bagguley, Debra Howell, Cathy Burton, Eve Roman, Russell Patmore

Health Sciences

Research output: Contribution to conference › Paper › peer-review

Original language	English
Publication status	Published - 2016
Event	Public Health England's Cancer Data and Outcomes conference - Duration: 1 Jun 2016 → 3 Jun 2016

Conference

Conference	Public Health England's Cancer Data and Outcomes conference
Period	1/06/16 → 3/06/16

Cite this

@conference{c06b0b6ac6f44b4cb76154f60267557b,

title = "Has the use of novel therapies improved survival in the general population of patients with myeloma and chronic lymphocytic leukaemia (CLL) in the UK?",

author = "Smith, {Alexandra Gwen} and Bagguley, {Timothy Charles} and Debra Howell and Cathy Burton and Eve Roman and Russell Patmore",

year = "2016",

language = "English",

note = "Public Health England's Cancer Data and Outcomes conference ; Conference date: 01-06-2016 Through 03-06-2016",